Cargando…

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Sainski, Amy M., Dai, Haiming, Natesampillai, Sekar, Pang, Yuan-Ping, Bren, Gary D., Cummins, Nathan W., Correia, Cristina, Meng, X. Wei, Tarara, James E., Ramirez-Alvarado, Marina, Katzmann, David J., Ochsenbauer, Christina, Kappes, John C., Kaufmann, Scott H., Badley, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195834/ http://dx.doi.org/10.1083/jcb.20140505109252014c

Ejemplares similares

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation
por: Sainski, Amy M., et al.
Publicado: (2014)

HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome
por: Natesampillai, Sekar, et al.
Publicado: (2018)

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
por: Cummins, Nathan W, et al.
Publicado: (2014)

Casp8p41 and HIV
por: Cummins, Nathan W., et al.
Publicado: (2015)

Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells
por: Natesampillai, Sekar, et al.
Publicado: (2010)

Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIV
por: Sampath, Rahul, et al.
Publicado: (2016)

TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes
por: Rizza, Stacey A., et al.
Publicado: (2011)

Infected Cell Killing by HIV-1 Protease Promotes NF-κB Dependent HIV-1 Replication
por: Bren, Gary D., et al.
Publicado: (2008)

Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells
por: Sampath, Rahul, et al.
Publicado: (2017)

Human Immunodeficiency Virus Envelope Protein Gp120 Induces Proliferation but Not Apoptosis in Osteoblasts at Physiologic Concentrations
por: Cummins, Nathan W., et al.
Publicado: (2011)

The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
por: Chandrasekar, Aswath P., et al.
Publicado: (2022)

Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization
por: Dai, Haiming, et al.
Publicado: (2011)

Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization
por: Pang, Yuan-Ping, et al.
Publicado: (2012)

Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria
por: Algeciras-Schimnich, Alicia, et al.
Publicado: (2007)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2
por: French, Andrea J., et al.
Publicado: (2020)

Eltrombopag directly activates BAK and induces apoptosis
por: Chen, Meng, et al.
Publicado: (2023)

Making sense of how HIV kills infected CD4 T cells: implications for HIV cure
por: Cummins, Nathan W, et al.
Publicado: (2014)

Therapeutic potential of HIV protease-activable CASP3
por: Miyauchi, Kosuke, et al.
Publicado: (2012)

HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells
por: Nie, Zilin, et al.
Publicado: (2008)

Characterization of an alternative BAK-binding site for BH3 peptides
por: Ye, Kaiqin, et al.
Publicado: (2020)

Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells
por: Dai, Haiming, et al.
Publicado: (2015)

Altering cell death pathways as an approach to cure HIV infection
por: Badley, A D, et al.
Publicado: (2013)

Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)

Playing FullBAK
por: Walensky, Loren D.
Publicado: (2013)

Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)

BAK-up: the receptor kinase BAK-TO-LIFE 2 enhances immunity when BAK1 is lacking
por: Fallahzadeh-Mamaghami, Vahid, et al.
Publicado: (2023)

Unsupervised Integration of Multiple Protein Disorder Predictors: The Method and Evaluation on CASP7, CASP8 and CASP9 Data
por: Zhang, Ping, et al.
Publicado: (2011)

Consequences of the combined loss of BOK and BAK or BOK and BAX
por: Ke, F, et al.
Publicado: (2013)

CASP+ Practice Tests
por: Tanner, Nadean
Publicado: (2020)

BAK additive influence on results
por: Shah, Rupali D, et al.
Publicado: (2013)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
por: Matyas, GR, et al.
Publicado: (2009)

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
por: Zhou, Heng, et al.
Publicado: (2015)

Cancer chemoresistance and BAK
por: Fox, Joanna L.
Publicado: (2015)

Small molecule SJ572946 activates BAK to initiate apoptosis
por: Sekar, Giridhar, et al.
Publicado: (2022)

Evaluation of model refinement in CASP13
por: Read, Randy J., et al.
Publicado: (2019)

Association Between a Polymorphism in CASP3 and CASP9 Genes and Ischemic Stroke
por: Lee, Bae Youl, et al.
Publicado: (2017)

Prime, shock and kill: BCL-2 inhibition for HIV cure
por: Chandrasekar, Aswath P., et al.
Publicado: (2022)

Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target
por: Iyer, Sweta, et al.
Publicado: (2020)

Optimizing single cell proteomics using trapped ion mobility spectrometry for label-free experiments
por: Mun, Dong-Gi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_faau9gs6lb6aq6b421jj1phh9l